Marbocare Flav Tablets 80mg
ANIMALCARE
Marbocare Flav Tablets 80mg from ANIMALCARE is supplied as a tablet.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Marbofloxacin
Pack & Presentation
Form: Tablet · Pack size: PK 72
Suitable Species
Dogs
Indications
Marbofloxacin is indicated in the treatment of the following infections caused by susceptible strains of organisms Marbocare flavour 5mg tablets for dogs and cats : Dogs Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis). Urinary tract infections (UTI) associated or not with prostatitis or epididymitis. Respiratory tract infections Cats Skin and soft tissue infections (wounds, abscesses, phlegmons).
Storage & Shelf Life
This veterinary medicinal product does not require any special storage conditions. Unused divided tablets should be returned to the blister pack and any divided tablet portions remaining after 96 hours (4 days) should be discarded.
Owner Handling & Safety
People with known hypersensitivity to (fluoro)quinolones should avoid using this product. Avoid contact of the skin and eyes with the product. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.
Contraindications & Warnings
Do not use in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer growth period. Do not use in cats aged less than 16 weeks. Do not use marbocare flavour 20mg and 80mg tablets in cats.
Use in Pregnancy & Lactation
Studies in laboratory animals (rats, rabbits) showed no teratogenicity, embryotoxicity and maternotoxicity with marbofloxacin at therapeutic doses. The safety of marbofloxacin has not been assessed in pregnant and lactating cats and dogs.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Emdoka Bvba, John Lijsenstraat 16, Hoogstraten B-2321, Belgium
- MA number: 5mg: UK (GB) Vm 34534/4003, UK (Northern Ireland) Vm 34534/4003 20mg: UK (GB) Vm 34534/4004, UK (Northern Ireland) Vm 34534/4004 80mg: UK (GB) Vm 34534/4005, UK (Northern Ireland) Vm 34534/4005
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
